Unlabeled nucleotides were purchased from GE Healthcare. [α32P]-Cordycepin (3′-dATP) and [γ32P]-ATP were obtained from Perkin Elmer Life Sciences. Substrates were radiolabeled at the 3′ end with [α32P]-Cordycepin and terminal deoxynucleotidyl transferase (TdT) or at the 5′ end with [γ32P]-ATP and T4 polynucleotide kinase (T4PNK). TdT, T4PNK, human AP endonuclease I (hAPE1), E. coli Uracil DNA Glycosylase (UDG) and E. coli EndoIII, were from New England Biolabs. Thrombin was obtained from Novagen. BsuLigD was purified as described (19 (link)).
Free full text: Click here